Demo Omnicell Sterile Compounds 
Omnicell
SEPTEMBER 5, 2022
Terri Albarano, PharmD Director, Autonomous Pharmacy, Omnicell Sterile compounding safety is one of the biggest challenges for the pharmacy supply chain. Health systems are expected to compound IV preparations with increasingly complex regulations, rising drug costs, and supply disruptions. billion in associated costs.
Omnicell
SEPTEMBER 5, 2022
David Webster Director of Acute Care Pharmacy Operations, University of Rochester Medical Center Sterile compounding is one of the most high risk, high cost areas of medication management. Manual compounding is fraught with error, studies indicating 1 in 10 IVs are not prepared according to guidelines.
Expert insights. Personalized for you.
52 
Let's personalize your content